Weight reduction in NAFLD patients reduces the delivery of free fatty acids (FFA) to the liver, improving extra-hepatic insulin sensitivity by means of a better peripheral glucose utilization. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.